Impact of Early versus Late Adherence to Highly Active Antiretroviral Therapy on Immuno-Virological Response: A 3-Year Follow-Up Study

Authors: Carrieri, Maria Patrizia, Raffi, François, Lewden, Charlotte, Sobel, Alain, Michelet, Christian, Cailleton, Valérie, Chêne, Geneviève, Leport, Catherine, Moatti, Jean-Paul, Spire, Bruno, Leport, C, Raffi, F, Chêne, G, Salamon, R, Moatti, J-P, Pierret, J, Brun-Vézinet, F, Fleury, H, Peytavin, G, Garraffo, R, Costagliola, D, Dellamonica, P, Katlama, C, Meyer, L, Morin, M, Sicard, D, Sobel, A, Ballereau, F, Bach, M-A, Bourdillon, F, Choutet, P, Delfraissy, J-F, Dormont, J, Souteyrand, Y, Vildé, J-L, Dupon, M, Le Moing, V, Marchou, B, May, T, Morlat, P, Waldner-Combernoux, A, Alfaro, C, Boucherit, S, Cailleton, V, Charlois, C, Droz, C, Duran, S, Ecobichon, JL, Egouy, C, Journot, V, Lassalle, R, Latour, L, Le Moing, V, Lewden, C, Masquelier, B, Nouioua, W, Palmer, G, Petit, C, Préau, M, Roloff, S, Savès, M, Spire, B, Winum, R

Source: Antiviral Therapy; August 2003, Vol. 8 Issue: 6 p585-594, 10p